We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Oneok
OKE
$58.4B
| $1.69M | 0.01% |
22,319
-13,465
| -38% | -$963K |
|
|
SC
802
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.69M | 0.01% |
72,200
-59,700
| -45% | -$1.45M |
|
|
DHC
803
Diversified Healthcare Trust
DHC
$1.92B
| $1.68M | 0.01% |
198,913
-395,900
| -67% | -$3.34M |
|
804
Smith & Wesson
SWBI
$586M
| $1.67M | 0.01% |
233,399
| – | – |
|
805
Jones Lang LaSalle
JLL
$15.7B
| $1.65M | 0.01% |
9,460
-10,200
| -52% | -$1.6M |
|
806
Curtiss-Wright
CW
$21.1B
| $1.64M | 0.01% |
11,600
-5,300
| -31% | -$718K |
|
|
CVSA
807
Covista Inc
CVSA
$4.33B
| $1.63M | 0.01% |
46,616
-4,019
| -8% | -$138K |
|
808
State Street
STT
$50.2B
| $1.62M | 0.01% |
20,507
-189,967
| -90% | -$13.4M |
|
|
AMAG
809
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.61M | 0.01% |
132,700
| – | – |
|
|
TBRG
810
DELISTED
TruBridge
TBRG
| $1.61M | 0.01% |
60,900
| – | – |
|
811
Ulta Beauty
ULTA
$22.7B
| $1.6M | 0.01% |
6,314
-277
| -4% | -$67.7K |
|
812
Advanced Energy
AEIS
$10.1B
| $1.58M | 0.01% |
22,221
+1,097
| +5% | +$68.3K |
|
|
PRSP
813
DELISTED
Perspecta Inc. Common Stock
PRSP
| $1.5M | 0.01% |
56,649
-288,282
| -84% | -$7.68M |
|
814
Dover
DOV
$25.4B
| $1.49M | 0.01% |
12,908
+137
| +1% | +$14.7K |
|
815
Saic
SAIC
$5.56B
| $1.49M | 0.01% |
17,097
| – | – |
|
816
Fortis
FTS
$27.5B
| $1.48M | 0.01% |
35,744
-884
| -2% | -$36.2K |
|
817
Corning
GLW
$124B
| $1.48M | 0.01% |
50,898
-6,764
| -12% | -$196K |
|
818
Vera Bradley
VRA
$114M
| $1.47M | 0.01% |
124,918
-3,561
| -3% | -$39.5K |
|
819
Etsy
ETSY
$6.74B
| $1.45M | 0.01% |
32,800
-50,300
| -61% | -$2.4M |
|
820
Invesco CurrencyShares Euro Currency Trust
FXE
$355M
| $1.45M | 0.01% |
13,602
| – | – |
|
|
RVI
821
DELISTED
Retail Value Inc. Common Shares
RVI
| $1.45M | 0.01% |
+427,954
| New | +$1.43M |
|
822
Core Laboratories
CLB
$525M
| $1.44M | 0.01% |
38,292
| – | – |
|
823
Sonic Automotive
SAH
$2.3B
| $1.43M | 0.01% |
+46,100
| New | +$1.46M |
|
|
NBL
824
DELISTED
Noble Energy, Inc.
NBL
| $1.4M | 0.01% |
56,284
+776
| +1% | +$16.5K |
|
825
Dolby
DLB
$5.5B
| $1.38M | 0.01% |
20,100
-10,500
| -34% | -$695K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.